Xuánjiā Biotech is a high-tech firm that applies natural ionic liquid technology to bio-new materials and broad health applications. The company develops and commercializes "supramolecular solvent," "supramolecular catalysis," and "supramolecular encapsulation" technologies and is one of China’s few suppliers of natural-source ionic liquids and deep eutectic solvents. It operates three R&D centers and has a 60+ person R&D team. Products developed include α-arbutin, VC glucoside, glyceryl glucoside products, L-carnitine series, kushen-alkaloid series, betaine series, glycyrrhizic-acid ionic liquid products and more than 100 cosmetic peptides. Xuánjiā’s industrial footprint covers cosmetics, health foods, disinfectants, medical devices, dietary supplements and biopharma, with production/industrial bases in Shaoguan, Zunyi, Zhuhai, Heyuan, Guizhou, Wenzhou and Kunming. The company provides ODM/OEM/OPM services, emphasizes high-quality lower-cost raw materials to build a moat, and plans to use investor support to boost R&D, improve technology translation, solidify product layout and optimize governance and operations; its valuation reached about RMB 600 million after the deal.

Total raised

$2M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2021